1. Home
  2. TPCS vs PDSB Comparison

TPCS vs PDSB Comparison

Compare TPCS & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

SELL

Current Price

$4.87

Market Cap

54.0M

Sector

Industrials

ML Signal

SELL

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.78

Market Cap

63.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPCS
PDSB
Founded
1956
2005
Country
United States
United States
Employees
N/A
10
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.0M
63.2M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
TPCS
PDSB
Price
$4.87
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $4.50
AVG Volume (30 Days)
17.0K
★ 4.7M
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.38
28.16
EPS
★ N/A
N/A
Revenue
★ $31,644,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.88
$0.20
52 Week High
$6.31
$1.79

Technical Indicators

Market Signals
Indicator
TPCS
PDSB
Relative Strength Index (RSI) 35.79 37.92
Support Level $4.42 $0.60
Resistance Level $5.76 $1.00
Average True Range (ATR) 0.30 0.14
MACD -0.03 -0.06
Stochastic Oscillator 10.86 5.22

Price Performance

Historical Comparison
TPCS
PDSB

About TPCS TechPrecision Corporation

Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: